Related Experiment Videos
Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
Liang Yang1, Xi Cheng1, Naijian Ge2
1Radiation Center, East Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 201805, China.
Oncotarget
|December 1, 2016
Summary
SPRY4-IT1, a long non-coding RNA, is upregulated in gallbladder carcinoma (GBC). Its knockdown inhibits GBC cell proliferation, migration, and invasion, suggesting SPRY4-IT1 as a potential therapeutic target for this bile duct cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gallbladder carcinoma (GBC) is a prevalent bile duct malignancy with poor patient outcomes.
- Long non-coding RNAs (lncRNAs) are frequently dysregulated in various cancers, including GBC.
- SPRY4-IT1 is recognized as an oncogenic regulator in multiple cancer types, but its role in GBC is unclear.
Purpose of the Study:
- To investigate the expression and function of SPRY4-IT1 in gallbladder carcinoma.
- To determine the impact of SPRY4-IT1 on GBC cell proliferation, migration, and invasion.
- To explore the potential of SPRY4-IT1 as a therapeutic target for GBC.
Main Methods:
- Quantitative analysis of SPRY4-IT1 expression in GBC tissues and cell lines.
- In vitro experiments involving SPRY4-IT1 knockdown in GBC cells.
- Assessment of cell proliferation, migration, and invasion following SPRY4-IT1 knockdown.
- Evaluation of the epithelial-mesenchymal transition (EMT) process in relation to SPRY4-IT1 function.
Main Results:
- SPRY4-IT1 expression was significantly upregulated in GBC tissues compared to normal tissues.
- Knockdown of SPRY4-IT1 markedly inhibited GBC cell proliferation in vitro.
- Reduced cell migration and invasion were observed upon SPRY4-IT1 knockdown.
- The inhibitory effects on migration and invasion were partly linked to the epithelial-mesenchymal transition (EMT) process.
Conclusions:
- SPRY4-IT1 acts as an oncogene in gallbladder carcinoma.
- SPRY4-IT1 upregulation promotes GBC cell proliferation, migration, and invasion.
- SPRY4-IT1 represents a promising candidate biomarker and therapeutic target for human GBC.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
01:32RNA Splicing
61.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.1K
03:18Non-LTR Retrotransposons
13.8K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.8K
02:07Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
02:18Alternative RNA Splicing
25.5K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.5K